The purpose of the Whistler Clinical Program for Alopecia Areata is to provide patients affected by alopecia areata with the most up to date treatments and to research new, and more effective treatments. The Whistler Clinical Program for Alopecia Areata Program sees patients around the world. The Program sees patients with some of the most challenging types of alopecia areata. Many of our recent publications are shown below.
Donovan JC. Successful treatment of corticosteroid resistant ophiasis type alopecia areata with platelet rich plasma. In Press.
Salsberg JM and Donovan J. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Arch Dermatol. 2012 Sep;148(9):1084-5.
Spano F and Donovan JC. Alopecia Areata. Part 1: Pathogenesis, Diagnosis and Prognosis: Canadian Family Physician. Sept 2015.
Spano F and Donovan JC. Alopecia Areata. Part 2: Treatment: Canadian Family Physician. Sept 2015.
Al Enazi M and Donovan JC. A Retrospective Review of DPCP Treatment in Adults with Alopecia Areata. Presented at the CDA Annual Meeting 2014.
Alopecia areata is an autoimmune condition that affects 2 % of the world's population. About 50 % of individuals with alopecia areata experience their first episode of alopecia areata before the age of 20. The cause remains unknown, although great progress has been made in the last 2-3 years to better understand potential causes.
There is no treatment in the world that helps all patients. However, the following treatments have the best evidence for treating alopecia areata and are prescribed at our Vancouver Office:
To make an appointment, simply contact our office
Yes!, Click the link below to read articles by Dr. Donovan on alopecia areata